José
Palacios Calvo
Profesor/a Titular Universidad
![Foto de José](/img/nophoto.png)
![Foto de Hospital Universitario 12 de Octubre](/img/noimage_org.png)
Hospital Universitario 12 de Octubre
Madrid, EspañaHospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (16)
2022
2021
-
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888
-
Tumor mutational burden assessment in non-small-cell lung cancer samples: Results from the TMB 2 harmonization project comparing three NGS panels
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5
2019
-
Clinical challenges and implications of intratumor heterogeneity
Revista Espanola de Patologia, Vol. 52, Núm. 4, pp. 234-241
2017
-
18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: A window-of-opportunity randomized trial
Clinical Cancer Research, Vol. 23, Núm. 6, pp. 1432-1441
-
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
JAMA oncology, Vol. 3, Núm. 12, pp. e173290
-
Treating KRAS -mutant NSCLC: Latest evidence and clinical consequences
Therapeutic Advances in Medical Oncology, Vol. 9, Núm. 9, pp. 589-597
2016
-
Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis
Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 3, pp. E328-E337
2013
-
DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification
Carcinogenesis, Vol. 34, Núm. 5, pp. 1031-1038
-
DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
British Journal of Cancer, Vol. 108, Núm. 8, pp. 1732-1742
2012
-
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
Journal of Pathology, Vol. 227, Núm. 1, pp. 42-52
2011
-
Consenso de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM) sobre la determinación de HER2 en el carcinoma gástrico
Revista Espanola de Patologia, Vol. 44, Núm. 1, pp. 32-48
2009
-
Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16
-
Guidelines for HER2 testing in breast cancer: A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 11, Núm. 6, pp. 363-375
2007
-
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis
Cancer Research, Vol. 67, Núm. 7, pp. 3450-3460
-
Sox2: A possible driver of the basal-like phenotype in sporadic breast cancer
Modern Pathology, Vol. 20, Núm. 4, pp. 474-481